Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril‐Valsartan: A Multicenter Echocardiographic Registry

Abstract Aims Sacubitril/valsartan has changed the treatment of heart failure with reduced ejection fraction (HFrEF), due to the positive effects on morbidity and mortality, partly mediated by left ventricular (LV) reverse remodelling (LVRR). The aim of this multicenter study was to identify echocar...

Full description

Bibliographic Details
Main Authors: Giulia Elena Mandoli, Maria Concetta Pastore, Alberto Giannoni, Giovanni Benfari, Frank Lloyd Dini, Gianmarco Rosa, Nicola Riccardo Pugliese, Claudia Taddei, Michele Correale, Natale Daniele Brunetti, Pietro Mazzeo, Erberto Carluccio, Anna Mengoni, Andrea Igoren Guaricci, Laura Piscitelli, Rodolfo Citro, Michele Ciccarelli, Giuseppina Novo, Egle Corrado, Annalisa Pasquini, Valentina Loria, Giuseppe De Carli, Anna Degiovanni, Giuseppe Patti, Ciro Santoro, Luca Moderato, Mariantonietta Cicoira, Marco Canepa, Alessandro Malagoli, Michele Emdin, Matteo Cameli
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.14155
_version_ 1827977121855700992
author Giulia Elena Mandoli
Maria Concetta Pastore
Alberto Giannoni
Giovanni Benfari
Frank Lloyd Dini
Gianmarco Rosa
Nicola Riccardo Pugliese
Claudia Taddei
Michele Correale
Natale Daniele Brunetti
Pietro Mazzeo
Erberto Carluccio
Anna Mengoni
Andrea Igoren Guaricci
Laura Piscitelli
Rodolfo Citro
Michele Ciccarelli
Giuseppina Novo
Egle Corrado
Annalisa Pasquini
Valentina Loria
Giuseppe De Carli
Anna Degiovanni
Giuseppe Patti
Ciro Santoro
Luca Moderato
Mariantonietta Cicoira
Marco Canepa
Alessandro Malagoli
Michele Emdin
Matteo Cameli
author_facet Giulia Elena Mandoli
Maria Concetta Pastore
Alberto Giannoni
Giovanni Benfari
Frank Lloyd Dini
Gianmarco Rosa
Nicola Riccardo Pugliese
Claudia Taddei
Michele Correale
Natale Daniele Brunetti
Pietro Mazzeo
Erberto Carluccio
Anna Mengoni
Andrea Igoren Guaricci
Laura Piscitelli
Rodolfo Citro
Michele Ciccarelli
Giuseppina Novo
Egle Corrado
Annalisa Pasquini
Valentina Loria
Giuseppe De Carli
Anna Degiovanni
Giuseppe Patti
Ciro Santoro
Luca Moderato
Mariantonietta Cicoira
Marco Canepa
Alessandro Malagoli
Michele Emdin
Matteo Cameli
author_sort Giulia Elena Mandoli
collection DOAJ
description Abstract Aims Sacubitril/valsartan has changed the treatment of heart failure with reduced ejection fraction (HFrEF), due to the positive effects on morbidity and mortality, partly mediated by left ventricular (LV) reverse remodelling (LVRR). The aim of this multicenter study was to identify echocardiographic predictors of LVRR after sacubitril/valsartan administration. Methods and results Patients with HFrEF requiring therapy with sacubitril/valsartan from 13 Italian centres were included. Echocardiographic parameters including LV global longitudinal strain (GLS) and global peak atrial longitudinal strain by speckle tracking echocardiography were measured to find the predictors of LVRR [= LV end‐systolic volume reduction ≥10% and ejection fraction (LVEF) improvement ≥10% at follow‐up] at 6 month follow‐up as the primary endpoint. Changes in symptoms [New York Heart Association (NYHA) class] and neurohormonal activations [N‐terminal pro‐brain natriuretic peptide (NT‐proBNP)] were also evaluated as secondary endpoints; 341 patients (excluding patients with poor acoustic windows and missing data) were analysed (mean age: 65 ± 10 years; 18% female, median LVEF 30% [inter‐quartile range: 25−34]). At 6 month follow‐up, 82 (24%) patients showed early complete response (LVRR and LVEF ≥ 35%), 55 (16%) early incomplete response (LVRR and LVEF < 35%), and 204 (60%) no response (no LVRR and LVEF < 35%). Non‐ischaemic aetiology, a lower left atrial volume index, and a higher GLS were all independent predictors of LVRR at multivariable logistic analysis (all P < 0.01). A baseline GLS < −9.3% was significantly associated with early response (area under the curve 0.75, P < 0.0001). Left atrial strain was the best predictor of positive changes in NYHA class and NT‐proBNP (all P < 0.05). Conclusions Speckle tracking echocardiography parameters at baseline could be useful to predict LVRR and clinical response to sacubitril–valsartan and could be used as a guide for treatment in patients with HFrEF.
first_indexed 2024-04-09T21:00:05Z
format Article
id doaj.art-c8131d0985ed4f18b6787e51d622d7b1
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-04-09T21:00:05Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-c8131d0985ed4f18b6787e51d622d7b12023-03-29T11:45:20ZengWileyESC Heart Failure2055-58222023-04-0110284685710.1002/ehf2.14155Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril‐Valsartan: A Multicenter Echocardiographic RegistryGiulia Elena Mandoli0Maria Concetta Pastore1Alberto Giannoni2Giovanni Benfari3Frank Lloyd Dini4Gianmarco Rosa5Nicola Riccardo Pugliese6Claudia Taddei7Michele Correale8Natale Daniele Brunetti9Pietro Mazzeo10Erberto Carluccio11Anna Mengoni12Andrea Igoren Guaricci13Laura Piscitelli14Rodolfo Citro15Michele Ciccarelli16Giuseppina Novo17Egle Corrado18Annalisa Pasquini19Valentina Loria20Giuseppe De Carli21Anna Degiovanni22Giuseppe Patti23Ciro Santoro24Luca Moderato25Mariantonietta Cicoira26Marco Canepa27Alessandro Malagoli28Michele Emdin29Matteo Cameli30Division of Cardiology, Department of Medical Biotechnologies University of Siena Viale Bracci 1 Siena ItalyDivision of Cardiology, Department of Medical Biotechnologies University of Siena Viale Bracci 1 Siena ItalyCardiology and Cardiovascular Medicine Department Fondazione Toscana G. Monasterio Pisa ItalySection of Cardiology, Department of Medicine University of Verona Verona ItalyCentro Medico Santagostino Milan ItalyDepartment of Internal Medicine and Medical Specialities University of Genoa Genoa ItalyDepartment of Clinical and Experimental Medicine University of Pisa Pisa ItalyCardiology and Cardiovascular Medicine Department Fondazione Toscana G. Monasterio Pisa ItalyCardiology Department Policlinico Riuniti University Hospital Foggia ItalyDepartment of Medical and Surgical Sciences University of Foggia Foggia ItalyDepartment of Medical and Surgical Sciences University of Foggia Foggia ItalyCardiology and Cardiovascular Pathophysiology—Heart Failure Unit, ‘Santa Maria della Misericordia’ Hospital University of Perugia Perugia ItalyCardiology and Cardiovascular Pathophysiology—Heart Failure Unit, ‘Santa Maria della Misericordia’ Hospital University of Perugia Perugia ItalyUniversity Cardiology Unit, Cardiothoracic Department Polyclinic University Hospital Bari ItalyUniversity Cardiology Unit, Cardiothoracic Department Polyclinic University Hospital Bari ItalyCardio‐Thoracic‐Vascular Department University Hospital San Giovanni di Dio e Ruggi d'Aragona Salerno ItalyDepartment of Medicine, Surgery and Dentistry University of Salerno Baronissi ItalyDivision of Cardiology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University Hospital Paolo Giaccone University of Palermo Palermo ItalyDivision of Cardiology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University Hospital Paolo Giaccone University of Palermo Palermo ItalyDepartment of Cardiovascular and Thoracic Sciences Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore Rome ItalyDepartment of Cardiovascular and Thoracic Sciences Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore Rome ItalyDivision of Cardiology, Department of Medical Biotechnologies University of Siena Viale Bracci 1 Siena ItalyDepartment of Thoracic, Heart and Vascular Diseases Maggiore della Carità Hospital Novara ItalyDepartment of Thoracic, Heart and Vascular Diseases Maggiore della Carità Hospital Novara ItalyDepartment of Advanced Biomedical Science Federico II University Hospital Naples ItalyCardiology Department Ospedale Guglielmo da Saliceto Piacenza ItalySection of Cardiology, Department of Medicine University of Verona Verona ItalyCardiovascular Disease Unit IRCCS Ospedale Policlinico San Martino, IRCCS Italian Cardiovascular Network Genoa ItalyDivision of Cardiology, Nephro‐Cardiovascular Department, Baggiovara Hospital University of Modena and Reggio Emilia Modena ItalyCardiology and Cardiovascular Medicine Department Fondazione Toscana G. Monasterio Pisa ItalyDivision of Cardiology, Department of Medical Biotechnologies University of Siena Viale Bracci 1 Siena ItalyAbstract Aims Sacubitril/valsartan has changed the treatment of heart failure with reduced ejection fraction (HFrEF), due to the positive effects on morbidity and mortality, partly mediated by left ventricular (LV) reverse remodelling (LVRR). The aim of this multicenter study was to identify echocardiographic predictors of LVRR after sacubitril/valsartan administration. Methods and results Patients with HFrEF requiring therapy with sacubitril/valsartan from 13 Italian centres were included. Echocardiographic parameters including LV global longitudinal strain (GLS) and global peak atrial longitudinal strain by speckle tracking echocardiography were measured to find the predictors of LVRR [= LV end‐systolic volume reduction ≥10% and ejection fraction (LVEF) improvement ≥10% at follow‐up] at 6 month follow‐up as the primary endpoint. Changes in symptoms [New York Heart Association (NYHA) class] and neurohormonal activations [N‐terminal pro‐brain natriuretic peptide (NT‐proBNP)] were also evaluated as secondary endpoints; 341 patients (excluding patients with poor acoustic windows and missing data) were analysed (mean age: 65 ± 10 years; 18% female, median LVEF 30% [inter‐quartile range: 25−34]). At 6 month follow‐up, 82 (24%) patients showed early complete response (LVRR and LVEF ≥ 35%), 55 (16%) early incomplete response (LVRR and LVEF < 35%), and 204 (60%) no response (no LVRR and LVEF < 35%). Non‐ischaemic aetiology, a lower left atrial volume index, and a higher GLS were all independent predictors of LVRR at multivariable logistic analysis (all P < 0.01). A baseline GLS < −9.3% was significantly associated with early response (area under the curve 0.75, P < 0.0001). Left atrial strain was the best predictor of positive changes in NYHA class and NT‐proBNP (all P < 0.05). Conclusions Speckle tracking echocardiography parameters at baseline could be useful to predict LVRR and clinical response to sacubitril–valsartan and could be used as a guide for treatment in patients with HFrEF.https://doi.org/10.1002/ehf2.14155Heart failureSacubitril/valsartanSpeckle trackingEchocardiographyRemodellingImaging
spellingShingle Giulia Elena Mandoli
Maria Concetta Pastore
Alberto Giannoni
Giovanni Benfari
Frank Lloyd Dini
Gianmarco Rosa
Nicola Riccardo Pugliese
Claudia Taddei
Michele Correale
Natale Daniele Brunetti
Pietro Mazzeo
Erberto Carluccio
Anna Mengoni
Andrea Igoren Guaricci
Laura Piscitelli
Rodolfo Citro
Michele Ciccarelli
Giuseppina Novo
Egle Corrado
Annalisa Pasquini
Valentina Loria
Giuseppe De Carli
Anna Degiovanni
Giuseppe Patti
Ciro Santoro
Luca Moderato
Mariantonietta Cicoira
Marco Canepa
Alessandro Malagoli
Michele Emdin
Matteo Cameli
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril‐Valsartan: A Multicenter Echocardiographic Registry
ESC Heart Failure
Heart failure
Sacubitril/valsartan
Speckle tracking
Echocardiography
Remodelling
Imaging
title Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril‐Valsartan: A Multicenter Echocardiographic Registry
title_full Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril‐Valsartan: A Multicenter Echocardiographic Registry
title_fullStr Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril‐Valsartan: A Multicenter Echocardiographic Registry
title_full_unstemmed Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril‐Valsartan: A Multicenter Echocardiographic Registry
title_short Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril‐Valsartan: A Multicenter Echocardiographic Registry
title_sort deformation imaging by strain in chronic heart failure over sacubitril valsartan a multicenter echocardiographic registry
topic Heart failure
Sacubitril/valsartan
Speckle tracking
Echocardiography
Remodelling
Imaging
url https://doi.org/10.1002/ehf2.14155
work_keys_str_mv AT giuliaelenamandoli deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT mariaconcettapastore deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT albertogiannoni deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT giovannibenfari deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT franklloyddini deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT gianmarcorosa deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT nicolariccardopugliese deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT claudiataddei deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT michelecorreale deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT nataledanielebrunetti deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT pietromazzeo deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT erbertocarluccio deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT annamengoni deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT andreaigorenguaricci deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT laurapiscitelli deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT rodolfocitro deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT micheleciccarelli deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT giuseppinanovo deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT eglecorrado deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT annalisapasquini deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT valentinaloria deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT giuseppedecarli deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT annadegiovanni deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT giuseppepatti deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT cirosantoro deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT lucamoderato deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT mariantoniettacicoira deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT marcocanepa deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT alessandromalagoli deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT micheleemdin deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry
AT matteocameli deformationimagingbystraininchronicheartfailureoversacubitrilvalsartanamulticenterechocardiographicregistry